← Browse by Condition
Medical Condition
hip dysplasia
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2, Phase 3, Phase 4
ClinicalMetric tracks all active clinical trials for hip dysplasia sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 2 1
Phase 3 1
Phase 4 1
Top Sponsors
1 trial
1 trial
1 trial
NCT06519955 Phase 2, Phase 3
Recruiting
Can PLIA Reduce Early Post-operative Pain After PAO Surgery?
Enrollment
120 pts
Location
United States
Sponsor
Michael C Willey
NCT07072832
Recruiting
Shelf Acetabuloplasty With 3D Printed Implants as a New Treatment for Symptomatic Adult Hip Dysplasia
Enrollment
10 pts
Location
Netherlands
Sponsor
Replasia BV
NCT07023094 Phase 4
Recruiting
PENG With LFCB vs. ESP Blocks for Pediatric Hip Surgery
Enrollment
60 pts
Location
Poland
Sponsor
Poznan University of Medical S...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology